Cathay Pacific has become the first airline in Hong Kong to be awarded IATA CEIV Pharma Certification, a globally-recognized pharmaceutical product handling accreditation.
The certification underlines the carrier’s capabilities in the treatment and transportation of high-value, time-sensitive and temperature-controlled pharmaceutical products with speed, consistency and efficiency.
In harness with aviation industry stakeholders and regulators, IATA created the Centre of Excellence for Independent Validators (CEIV) with the aim of helping organizations involved in the air cargo supply chain achieve pharmaceutical handling excellence.
CEIV Pharma Certification addresses the industry’s needs for safety, security, compliance and efficiency in the transportation of pharmaceutical products. It seeks to minimize product loss attributed to handling and environmental factors during transport.
The certification encompasses, and in some cases exceeds, existing pharmaceutical standards and guidelines such as the European Union’s Good Distribution Practice and the World Health Organization (Annex 5) Good Distribution Practices for Pharmaceutical Products.
Cathay Pacific Director Commercial and Cargo Ronald Lam said: “It is a great honor to have been awarded IATA CEIV Pharma Certification, which recognizes our commitment to our pharmaceutical customers. Cathay Pacific Cargo adheres to the highest operating standards and this certification highlights our capabilities in handling these precious, time-sensitive and often life-saving shipments.”